CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 75 filers reported holding CARA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,433,000 | -19.2% | 692,518 | -27.4% | 0.00% | -50.0% |
| Q3 2016 | $7,966,000 | +83.3% | 954,036 | +5.6% | 0.00% | +100.0% |
| Q2 2016 | $4,347,000 | -19.7% | 903,747 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $5,413,000 | -62.4% | 870,309 | +2.0% | 0.00% | -66.7% |
| Q4 2015 | $14,384,000 | +11.5% | 853,145 | -5.5% | 0.00% | 0.0% |
| Q3 2015 | $12,903,000 | +43.9% | 902,949 | +22.4% | 0.00% | +50.0% |
| Q2 2015 | $8,965,000 | +100.1% | 737,882 | +65.5% | 0.00% | +100.0% |
| Q1 2015 | $4,481,000 | +7.7% | 445,858 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $4,161,000 | +280.7% | 417,388 | +220.3% | 0.00% | – |
| Q3 2014 | $1,093,000 | -52.7% | 130,322 | -4.0% | 0.00% | -100.0% |
| Q2 2014 | $2,310,000 | -16.3% | 135,696 | -8.5% | 0.00% | 0.0% |
| Q1 2014 | $2,760,000 | – | 148,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |